Oppenheimer’s Steven Lichtman now bets on 6% in return potential for TNDM stock, with eyes on a new driver: a forthcoming international launch.
Tandem Diabetes Care Inc (NASDAQ:TNDM) hit a preliminary home run with its first quarter earnings show for 2018, releasing an exciting revenue beat …
